Subunit protein vaccine of recombinantly expressed Marburg Marburgvirus glycoprotein (MARV GP, MarVax)

N/A

Report date: 2024/04/16 10:50:53

Base Information

Drug NameSubunit protein vaccine of recombinantly expressed Marburg Marburgvirus glycoprotein (MARV GP, MarVax)
Drug Alias NameMarVax™
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMarburg Virus Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSoligenix Inc
China Registration ClassN/A

Develop Information

Active CompaniesSoligenix Inc
Inactive CompaniesN/A
Active IndicationsMarburg Virus Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A